An overview of our treatment centers follows with links to more comprehensive information at our sites of care.

An overview of our treatment centers follows with links to more comprehensive information at our sites of care.

Cutaneous (Skin)

The cutaneous treatment centers provide a range of services, including screening of high-risk individuals to providing the most innovative treatments, including investigational therapies, to patients with all types and stages of melanoma and non-melanoma skin cancers.

The centers' services are provided by a team of specialists in dermatology, dermatopathology, surgical oncology, and medical oncology, with consultative support by radiation oncologists, neurosurgeons, plastic surgeons, and nuclear medicine specialists.

These centers provide one-time consultation and second opinions; prevention and early-detection counseling; genetic counseling and risk assessment; screening of high-risk individuals; histopathologic diagnosis and review; and the latest treatments, including Mohs surgery, immunotherapy, photon radiosurgery, and stereotactic radiosurgery. Patients also have access to clinical trials, including investigations of new immunologic therapies.

Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center